Physician profile
Valerie Biousse
NPI 1144248972
$28,440.75
in general payments reported to CMS, 2019-2025
6 companies · $12K in 2025
The $12K reported for 2025 was more than what 94% of Neuro-Ophthalmology providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,255 · 2022: $49.73 · 2023: $104 · 2024: $15K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $3,159 · Food and Beverage: $907 · Honoraria: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,650.00 |
| Travel and Lodging | $3,158.78 |
| Food and Beverage | $907.22 |
| Honoraria | $420.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Topcon Healthcare, INC. | $22,440.50 | 2024-2025 | |
| Chiesi USA, INC. | $4,516.70 | 2025 | |
| Biogen, INC. | $1,255.02 | 2019 | |
| Alcon Vision LLC | $104.25 | 2023 | Acrysof Iq Panoptix Uv Iol |
| Argenx US, INC. | $74.55 | 2025 | Vyvgart Hytrulo |
| Horizon Therapeutics Plc | $49.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valerie Biousse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.